Seeking Alpha

Biogen Idec (BIIB +4%) moves higher after BofA/ Merrill Lynch upgrades the shares to Buy from...

Biogen Idec (BIIB +4%) moves higher after BofA/ Merrill Lynch upgrades the shares to Buy from Neutral. Price target raised to $246 from $187.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|